Evidence map›Paper›PMID 20460125›Full record

ArticleInternational journal for parasitology2010

Low infectivity of Plasmodium falciparum gametocytes to Anopheles gambiae following treatment with sulfadoxine-pyrimethamine in Mali.

Abdoul H Beavogui, Abdoulaye A Djimde, Aric Gregson, Abdoulaye M Toure, Adama Dao, Boubacar Coulibaly, Dinkorma Ouologuem, Bakary Fofana, Adama Sacko, Mamadou Tekete and 6 more

Open access · greenAbstract read
In one paragraph

Article in International journal for parasitology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Prevalence ofPathogens (Basel, Switzerland) · 2026
    Article
  8. A NovelAntimicrobial agents and chemotherapy · 2022
    Article
  9. HIV-1 Impact on Malaria Transmission: A Complex and Relevant Global Health Concern.Frontiers in cellular and infection microbiology · 2021
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 3 countries.

Abdoul H BeavoguiMalaria Research and Training Center, Department of Epidemiology of Parasitic Diseases, University of Bamako, P.O. Box 1805, Point G, Bamako, Mali.
Abdoulaye A Djimde
Aric Gregson
Abdoulaye M Toure
Adama Dao
Boubacar Coulibaly
Dinkorma Ouologuem
Bakary Fofana
Adama Sacko
Mamadou Tekete
Aminatou Kone
Oumou Niare
Mamadou Wele
Christopher V Plowe
Stephane Picot
Ogobara K Doumbo
University of Bamako · MLUniversité Claude Bernard Lyon 1 · FRHoward Hughes Medical Institute · USUniversity of Maryland, Baltimore · US

Funding

Genetic diversity and protective immunity to malaria infection and diseaseU01AI065683 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI PLOWE, CHRISTOPHER V. · 2010 to 2014
$3.0M
DRUG-RESISTANT MALARIA IN MALAWIR01AI044824 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI PLOWE, CHRISTOPHER V. · 1999 to 2002
$1.1M
Howard Hughes Medical Institute 55005502NIAID NIH HHS 5 RO1 AI44824-03NIAID NIH HHS R01 AI044824NIAID NIH HHS U01 AI065683
6 · The paper itself

Abstract

Sulfadoxine-pyrimethamine (SP) treatment increases the rate of gametocyte carriage and selects SP resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase (DHFR) and dihydropteroate synthase (DHPS), raising concerns of increased malaria transmission and spread of drug resistance. In a setting in Mali where SP was highly efficacious, we measured the prevalence of DHFR and DHPS mutations in P. falciparum infections with microscopy-detected gametocytes following SP treatment, and used direct feeding to assess infectivity to Anopheles gambiae sensu lato. Children and young adults presenting with uncomplicated malaria were treated with SP or chloroquine and followed for 28 days. Gametocyte carriage peaked at 67% 1 week after treatment with a single dose of SP. Those post-SP gametocytes carried significantly more DHFR and DHPS mutations than pre-treatment asexual parasites from the same population. Only 0.5% of 1728 mosquitoes fed on SP-treated gametocyte carriers developed oocysts, while 11% of 198 mosquitoes fed on chloroquine-treated gametocyte carriers were positive for oocysts. This study shows that in an area of high SP efficacy, although SP treatment sharply increased gametocyte carriage, the infectiousness of these gametocytes to the vector may be very low. Accurate and robust methods for measuring infectivity are needed to guide malaria control interventions that affect transmission.

Indexed as

AnimalsAnophelesAntimalarialsDihydropteroate SynthaseDrug CombinationsGene Expression Regulation, EnzymologicHumansMalaria, FalciparumMaliPlasmodium falciparumPyrimethamineSulfadoxineTetrahydrofolate DehydrogenaseAntimalarialsDihydropteroate SynthaseDrug Combinationsfanasil, pyrimethamine drug combinationPyrimethamineSulfadoxineTetrahydrofolate Dehydrogenase

Identifiers

PMID20460125
PMCPMC3571761
OpenAlexW2099194811

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.